Is GSK guilty of fraud?
D000293:Adolescent; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D003866:Depressive Disorder / Q000188:drug therapy*; D030881:Disclosure / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004346:Drug Information Services / Q000331:legislation & jurisprudence; D006801:Humans; D009518:New York; D017374:Paroxetine / Q000009:adverse effects / Q000627:therapeutic use*; D015871:Scientific Misconduct / Q000331:legislation & jurisprudence*; D016896:Treatment Outcome
D018687:Antidepressive Agents, Second-Generation; D017374:Paroxetine